Does Health Net Cover Metformin?

How Health Net Formularies Work

Health Net organizes covered drugs into tiers. Tier 1 drugs carry the lowest member cost-share, and generic medications like metformin almost always sit there. Understanding the tier structure helps you predict what you will owe at the pharmacy counter before you ever hand over your insurance card.

Tier Structure Basics

Health Net's commercial plans typically run a 4-to-5-tier formulary. Tier 1 is preferred generics, Tier 2 is non-preferred generics or preferred brands, Tier 3 is non-preferred brands, and Tiers 4 or 5 cover specialty drugs. Metformin hydrochloride, the generic form, almost exclusively lands on Tier 1 across Health Net's product lines.

Medi-Cal vs. Commercial vs. Medicare Advantage

Health Net administers Medi-Cal managed care plans in California. The California Medi-Cal Drug List includes metformin as a covered medication with no copay for most beneficiaries. For Medicare Advantage members, Health Net must include metformin on its Part D formulary because the Centers for Medicare and Medicaid Services (CMS) classifies it as a protected-class-adjacent essential diabetes drug. Copays on Medicare Advantage plans are commonly $0 to $10 at preferred network pharmacies.

How to Confirm Your Specific Coverage

The single most reliable step is running your plan's formulary lookup. Health Net maintains a searchable drug list at its member portal. You can also call member services at the number on the back of your card. Asking for the "formulary drug tier" and "applicable cost-share" for NDC 0093-1047 (a common metformin 500 mg generic) gives the representative a precise search term and speeds the call.

What Metformin Is and Why Insurers Cover It

Metformin is a biguanide oral hypoglycemic agent approved by the FDA in 1994 for the management of type 2 diabetes mellitus in adults. The FDA label was later expanded to include pediatric patients aged 10 and older [1]. Because metformin has been off patent for decades, its generic manufacturing cost is extremely low, which makes it economically rational for any formulary to place it at Tier 1.

Clinical Evidence That Drives Coverage Decisions

Payers classify drugs partly on the strength of their clinical evidence. Metformin's evidence base is one of the deepest in oral diabetes therapy.

The United Kingdom Prospective Diabetes Study (UKPDS 34, N=1,704) found that intensive blood-glucose control with metformin in overweight patients with type 2 diabetes reduced the risk of any diabetes-related endpoint by 32% (P<0.002) compared with conventional diet therapy, and reduced all-cause mortality by 36% (P<0.011) [2]. Those numbers made metformin a standard-of-care agent, and standard-of-care agents are almost never excluded from formularies.

The American Diabetes Association's 2024 Standards of Care in Diabetes states: "Metformin remains an effective, low-cost medication that reduces cardiovascular risk and should be continued when tolerated and not contraindicated in patients with type 2 diabetes" [3]. Insurers use guideline alignment as a formulary justification, so ADA endorsement is directly relevant to coverage.

FDA-Approved Indications That Trigger Coverage

Health Net's medical necessity criteria typically require a drug to have an FDA-approved indication that matches the diagnosis code on the prescription. For metformin, the relevant ICD-10 codes are:

• E11.9 (Type 2 diabetes mellitus without complications)
• E11.65 (Type 2 diabetes mellitus with hyperglycemia)
• R73.09 (Other abnormal glucose, used for prediabetes off-label)

Prescriptions written for type 2 diabetes (E11.x) will almost never trigger a prior authorization request because metformin is the guideline-recommended first-line agent. Off-label uses such as prediabetes prevention, polycystic ovary syndrome (PCOS), or longevity/anti-aging purposes may face additional review, though coverage for PCOS-related metformin prescriptions is increasingly common as clinical guidelines from the American College of Obstetricians and Gynecologists (ACOG) include it as an option [4].

Cost-Sharing: What You Will Actually Pay

Generic metformin is one of the least expensive prescription drugs in the United States. Even without insurance, a 90-day supply of metformin 500 mg twice daily (180 tablets) costs roughly $10 to $20 at major chains. With Health Net coverage at Tier 1, members in many plans pay $0 to $10 for a 30-day supply and $0 to $15 for a 90-day supply through mail order.

Copay Ranges by Plan Type

| Plan Type | Typical Tier | 30-Day Copay | 90-Day Mail Order | |---|---|---|---| | Health Net Commercial (HMO/PPO) | Tier 1 | $5 to $15 | $10 to $30 | | Health Net Medi-Cal | Tier 1 | $0 to $1 | N/A (30-day fills) | | Health Net Medicare Advantage | Tier 1 | $0 to $10 | $0 to $20 |

Note: These figures reflect typical 2024 plan designs. Your Summary of Benefits and Coverage (SBC) document governs actual cost-sharing.

Deductibles and Accumulator Programs

Some Health Net commercial plans apply a separate drug deductible before cost-sharing kicks in. If your plan has a $250 annual drug deductible, you pay the negotiated generic price (often $4 to $20) until the deductible is met, then your Tier 1 copay applies. Check your SBC under "Prescription Drug Coverage" for this detail.

When Health Net Might Not Cover Metformin

Extended-Release Formulations and Brand Names

Standard immediate-release metformin is covered on essentially every Health Net formulary. Extended-release formulations (metformin ER, Glucophage XR, Fortamet, Glumetza) may sit at a higher tier or require that the member try immediate-release first. Brand-name Glucophage is rarely covered when a generic is available, consistent with Health Net's standard generic-substitution policy.

In April 2020, the FDA requested that Apotex Corp. And several other manufacturers recall certain extended-release metformin products due to N-nitrosodimethylamine (NDMA) contamination above acceptable limits [5]. Some formularies temporarily restricted specific ER NDCs during that period. Current ER formulations on the market have passed FDA quality standards, and coverage has normalized.

Off-Label Prescriptions

When a physician prescribes metformin for prediabetes prevention rather than established type 2 diabetes, some plans may require a prior authorization form documenting fasting glucose values or HbA1c results. The Diabetes Prevention Program (DPP, N=3,234) showed that metformin 850 mg twice daily reduced progression from prediabetes to type 2 diabetes by 31% over 2.8 years (P<0.001) compared with placebo [6]. That data is compelling to any medical director reviewing a PA request, so providing it in the appeal is wise.

Plan Non-Coverage Scenarios

A small number of Health Net "Savings" or short-term limited-duration plans carry restricted formularies that may exclude even Tier 1 generics. These are not ACA-compliant plans, meaning they are not required to cover essential health benefits. If you are on a limited-duration or fixed-indemnity plan, call member services to verify metformin is listed before filling.

How to Request a Prior Authorization or Appeal a Denial

Step 1: Get the Denial Reason in Writing

If Health Net denies coverage, federal law (the No Surprises Act and ACA Section 2719) requires the plan to provide a written explanation. Ask for the Explanation of Benefits (EOB) and the specific formulary exclusion code.

Step 2: Submit a Prior Authorization

Your prescribing physician submits a PA form to Health Net's pharmacy benefits manager. The form should include:

• Diagnosis code (E11.9 or relevant ICD-10)
• Most recent HbA1c or fasting glucose result
• Confirmation that no contraindications exist (the FDA label lists an eGFR <30 mL/min/1.73m² as a contraindication) [1]
• Rationale referencing ADA Standards of Care 2024

Step 3: File a Formal Internal Appeal

Health Net must respond to an internal appeal within 30 days for standard requests and 72 hours for urgent cases under 45 CFR Part 147. Include the UKPDS 34 data [2] and the ADA guideline statement [3] in your appeal packet.

Step 4: Request an Independent Medical Review (California)

California residents covered under California-regulated plans may request an Independent Medical Review (IMR) through the California Department of Managed Health Care (DMHC) if the internal appeal fails. The DMHC resolves most IMRs within 30 days. Studies show that patients who use the IMR process prevail in roughly 40% to 50% of cases involving evidence-based medications [7].

Alternatives If You Cannot Get Coverage Approved

Retail Generic Programs

Several major pharmacy chains sell metformin at discounted cash prices entirely outside the insurance system:

• Walmart's $4 generic list includes metformin 500 mg and 1000 mg (30-day supply)
• Kroger, Publix, and Meijer carry similar $4-to-$5 programs
• Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists metformin 500 mg at approximately $0.02 per tablet

GoodRx and Similar Discount Programs

GoodRx coupons can reduce the cash price of metformin 500 mg (60 tablets) to $4 to $9 at most major chains. These coupons are processed as a cash transaction and cannot be combined with insurance for the same fill, but they are useful when the insurance copay exceeds the coupon price.

Manufacturer and Patient Assistance Programs

Metformin is generic, so there is no branded manufacturer patient assistance program. However, NeedyMeds (needymeds.org) maintains a database of state pharmaceutical assistance programs that may cover metformin for low-income patients who do not qualify for Medi-Cal.

Metformin's Role in Longevity and Preventive Medicine

Beyond diabetes management, metformin has attracted serious scientific attention as a potential aging-modifying agent. The Targeting Aging with Metformin (TAME) trial, a multi-site study funded by the American Federation for Aging Research, is enrolling approximately 3,000 adults aged 65 to 79 without diabetes to test whether metformin 1,500 mg/day can delay the incidence of age-related conditions including cardiovascular disease, cancer, dementia, and mortality [8]. TAME is the first FDA-recognized trial specifically designed to test a drug against the aging process itself, meaning the FDA acknowledged "aging" as a potential trial endpoint category.

What the Basic Science Shows

Metformin activates AMP-activated protein kinase (AMPK), a cellular energy sensor that mimics some effects of caloric restriction. In animal models, metformin extended lifespan by 5% to 6% in mice when started in midlife [9]. Whether that translates to humans is exactly what TAME is designed to determine.

What This Means for Coverage of Longevity Prescriptions

No commercial insurer, including Health Net, currently covers metformin prescribed exclusively for longevity or anti-aging purposes because the FDA has not approved that indication. If a prescriber lists "longevity" as the sole diagnosis, the claim will be denied. The practical workaround for patients who want metformin for longevity is an established comorbidity (prediabetes, PCOS, or insulin resistance with metabolic syndrome) that supports a covered ICD-10 code, combined with a physician who agrees that metformin is clinically appropriate for that indication.

Dr. Nir Barzilai, the principal investigator of the TAME trial, has stated publicly that "metformin is the leading candidate for a geroscience-guided clinical trial because of its safety profile, low cost, and decades of human data" [8]. That safety record is partly why coverage denials for this drug are unusual when a legitimate diabetes or prediabetes diagnosis is documented.

Practical Steps for Health Net Members

Confirm Your Formulary Today

Log in to the Health Net member portal, select "Drug Lookup," and search for "metformin hydrochloride." The tool returns the tier, any PA requirements, and your plan-specific copay. Take a screenshot for your records.

Talk to Your Prescriber About Diagnosis Documentation

If you have prediabetes (HbA1c 5.7% to 6.4% per CDC criteria) [10] and your physician believes metformin is appropriate, make sure the prescription carries the correct ICD-10 code. The DPP trial showed a 31% risk reduction with metformin in this population [6], which provides strong clinical backing for the prescription.

Use a 90-Day Supply

Most Health Net plans reduce the per-unit cost when members fill a 90-day supply through mail order rather than a 30-day supply at retail. For a drug like metformin that is taken long-term, mail-order is almost always the lower-cost option.

Coordinate With Your Pharmacist

Pharmacists can run a real-time eligibility check before the prescription is submitted, flagging any PA requirements before you make a trip to the counter. This takes about two minutes and prevents surprises.